Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) granted inducement awards on December 1, 2025 to a newly hired employee under its 2023 Inducement Plan.

The awards permit purchase of up to 15,500 shares of common stock. Options vest over a four-year schedule: 25% of the shares vest on the one-year anniversary of the vesting commencement date, then 1/48th of the shares vest monthly for the remaining 36 months, subject to continued service.

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on December 1, 2025, the Company granted inducement awards to purchase up to 15,500 shares of common stock to one new employee under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

About Syndax
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj^® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.

Syndax Contact

Sharon Klahre 
Syndax Pharmaceuticals, Inc. 
sklahre@syndax.com
Tel 781.684.9827

FAQ

What did Syndax (SNDX) announce on December 3, 2025 about an inducement grant?

Syndax announced it granted inducement awards on Dec 1, 2025 to purchase up to 15,500 shares to a new employee under its 2023 Inducement Plan.

How do the Syndax (SNDX) inducement options vest?

Options vest over four years: 25% at the one-year anniversary, then 1/48th monthly for the next 36 months, subject to continued service.

How many shares did Syndax (SNDX) grant in the inducement award?

The inducement award permits purchase of up to 15,500 shares of common stock.

Under which plan were the Syndax (SNDX) inducement awards granted?

The awards were granted under Syndax's 2023 Inducement Plan.

Who received the Syndax (SNDX) inducement awards?

The awards were granted to one new employee as an inducement hire.

Will the Syndax (SNDX) inducement options vest if the employee leaves early?

Vesting is subject to the employee's continued service through each applicable vesting date, so early departure would generally forfeit unvested shares.